The document outlines Endo Pharmaceuticals' corporate compliance program, emphasizing that it is a comprehensive system designed to prevent and detect violations of laws and regulations beyond a simple code of conduct. It discusses various elements necessary for an effective compliance program, such as designated officers, written policies, and ongoing training, while noting the challenges of maintaining such programs in terms of costs and resources. Recommendations for ongoing improvement in compliance are provided, alongside findings on the necessity of continuous adaptation to legal and cultural changes.

1. Endo Pharmaceuticals corporate
compliance program

2. Introduction
A corporate compliance program is generally defined as a formal program specifying an
organization’s policies, procedures, and actions within a process to help prevent and
detect violations of laws and regulations. It goes beyond a corporate code-of-conduct
since it is an operational program, not simply a code of expected ethical behavior. Clearly,
a code-of-conduct is an important component of a compliance program and ethics
remains the heart and soul of all corporate compliance programs. It is essentially a
codification of applicable regulatory and internal compliance requirements, as well as a
roadmap to action. A comprehensive program helps position a company to divert
disasters, meet objectives, and grow shareholder value. Many organizations have
components of a program in place.

3. Literature Review
According to Hess (1996), corporate compliance is the process of administration and control of
the firm’s human resources and capital in the firm’s owner’s interest. The Centre of European
Policy Studies (CEPS, 1995) indicates, in describing corporate governance, that it acts as a whole
system of processes, rights and controls that is expanded externally and internally over the
entity of business management with the aim of protecting stakeholders’ interests. Shleifer and
Vishny (1997) refer to corporate compliance as being a way in which the corporation’s financial
suppliers ensure that they will receive an investment return. According to O’Donovan (2003),
corporate compliance is an internal system that includes processes, policies and people that
serve the requirements of shareholders as well as other stakeholders by controlling and
directing activities by the firm’s management with good business objectivity, savvy and integrity

4. Topic related theories/frameworks
Some external government requirements related to
compliance include:
 ANNUAL STATEMENT OR REPORT
 FRANCHISE TAX
 THE FAIR LABOUR STANDARDS ACT
There are some suggestions for internal compliance.
These are:
 PHYSICAL ENTRANCE POLICIES
 VIRTUAL ACCESS
 PASSWORD PROTECTION
 SECURITY UPDATES
 VIRUS PROTECTION
 EMERGENCY RESPONSE
The basic standards of compliance ensured
by those factors :
 HUMAN RESOURCES
 REDUCED LEGAL PROBLEMS
 IMPROVED OPERATIONS
 WORKPLACE SAFETY
 FINANCIAL SERVICES
 BETTER PUBLIC RELATIONS
 DATA SECURITY
 HIGHER EMPLOYEE RETENTION

5. Methodology of the Study
Secondary sources of data:
Information has been collected from-
Various study reports. relevant books,
journal and printed materials. Website of
the company. We mainly collected
information from different article on
corporate compliance, Endo's website.
To prepare the report on Endo's Global Compliance
Program the information has been collected from
secondary sources.
In the most ceases methodology of the study happen
through two sources.
Those are :
• Primary sources of data
• Secondary sources of data
This report mainly prepared from Secondary sources.

6. DISCUSSIONS OF THE TOPIC
Basic corporate compliance Functions related to
Endo Pharmaceuticals :
• Corporate Compliance & Business Practices
• Endo's Culture of Compliance
• Leadership Responsibilities
• Code of Conduct
• Reporting a Concern
• How to Raise a Concern
Elements of an Effective Compliance Program:
 Designated compliance officer and compliance
committee
 Written policies and procedures
 Effective training and education
 Open lines of communication
 Internal monitoring and auditing
 Enforcement of standards through disciplinary
guidelines

7. FINDINGS
 Developing, implementing and maintaining corporate compliance program within an
organization can be expensive and time-consuming.
 Proper administration of corporate compliance program often requires the hiring of an ethics
officer and the commitment of company financial and personnel resources.
 It requires the comprehensive support of management to be effective that is very difficult.
 Corporate compliance policies need to be continually updated to reflect changes in
workplace laws and changes in the company culture which is very challenging.
 It is found that Corporate Compliance and Business Practices department has to establish a
core mission and strategy to create and maintain a culture of compliance.
 Companies with international activities not only have to adhere to domestic laws, but also
have to monitor compliance with the laws and norms of behavior in other legal systems and
other cultures

8. RECOMMENDATIONS
 Establish routine review & compliance training with expected outcomes
 Follow up with further review & Training in non-compliance area
 Update training on regular basis & periodically review billing & clinical record for accuracy
 Notify compliance officer, Chief operating officer & Executive Officer of uncorrected
compliance issue.
 Notify compliance officer, Chief operating officer & corporate compliance officer, Human
resource Manager of additional disciplinary actions.
 Issue with warning of non-compliance with copies to the corporate compliance officer

9. CONCLUSIONS
 Discussed about corporate compliance program Specially Endo Pharmaceuticals corporate
compliance program.
 Here is discussed about Some external government requirements related to compliance,
Elements of an Effective Compliance Program, Corporate Compliance & Business Practices,
Endo's Culture of Compliance, Leadership responsibilities, Code of Conduct, Reporting a
Concern, Findings from corporate compliance.
 The study is performed based on the information extracted from different sources collected
by using a specific methodology.
 This report is analytical in nature.
 To prepare the report on corporate compliance policy and procedure of Endo
Pharmaceuticals.
 The information has been collected from secondary sources.

10. References
 Ahammad, T. (2018) The case for corporate compliance programmes.
thefinancialexpress August 18. Available from
https://thefinancialexpress.com.bd. [ July 8, 2019]
 Adam, A., Rachman-Moore, D., (2004), “The Methods Used to Implement an
Ethical Code of Conduct and Employee Attitudes,” Journal of Business Ethics,
Vol. 54, pp. 225-244
 Josephs, Al. 2001. "A Conversation with Kristin Jenkins, Compliance and Quality
Officer." Compliance Today 3(5): 13–19.
 S.J. Griffith, “Corporate Governance in an Era of Compliance,” William & Mary
Law Review 57, no. 6 (May 2016): 2102-2103; and R.M. Steinberg, “The High
Cost of Non-Compliance: Reaping the Rewards of an Effective Compliance
Program” (February 2010), www.securityexecutivecouncil.com.
Websites:
• http://
www.thefinancialexpress.
com.bd
• http://www.endo.com/en
dopharma/about-
us/corporate-compliance